title: An unusual case of massive subcutaneous chest wall haemorrhage with enoxaparin.
abstract: Enoxaparin is used in the treatment of acute coronary syndromes and offers improved outcome in the composite endpoint of death, myocardial infarction and major bleeding when compared with unfractionated heparin (UFH). Our report describes a rare case of massive life-threatening subcutaneous chest wall haemorrhage, distant to the injection site. Clinicians should be aware of atypical presentations of haemorrhage when using combination antiplatelet and antithrombotic therapy.
authors: Mohammed Shamim
authors: MS
authors: Rahman
authors: Lin
authors: L
authors: Soo
authors: Asif
authors: A
authors: Qasim
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced / Q000175:diagnosis*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D035441:Thoracic Wall
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin